PATENT CLAIM ANALYSIS

Application Number: 15927170
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["514", "230500"]

Abstract:
The present invention relates to substituted pyrrolopyridinones and substituted pyrazolopyridinones which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.

Claim (Index 94):
The method of  claim 91 , wherein the cancer is multiple myeloma, AML, or DLBCL.

Metadata:
- Claim Count in Document: 126.0
- Percentile: 90.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14554306', '15354223', '15088373', '14554263', '15906163']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8574648722070853
- 35 USC 102 Novelty (BERT): 0.5942365706857745
- Combined Prediction Score: 0.8311420420549542
- Mean Citation Score: 555.065632
- Max Citation Score: 614.763
- Similarity Product: 415.3413898108007

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test